|
Sign In to gain access to subscriptions and/or personal tools.
|
Clinical Trials, Vol. 5, No. 3,
262-272 (2008)
DOI: 10.1177/1740774508091676
SAGE Open article
Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
Wendy Demark-Wahnefried
Division of Cancer Prevention & Control/Department of Behavioral Science, MD Anderson Cancer Center, Houston, TX USA, wdemarkw{at}mdanderson.org
Stephen L George
Department of Biostatistics, Duke University Medical Center (DUMC), Durham, NC, USA
Boyd R Switzer
Department of Nutrition, University of North Carolina, Chapel Hill, NC, USA
Denise C Snyder
Duke School of Nursing, Durham, NC, USA
John F Madden
Department of Pathology, DUMC, Durham, NC, USA
Thomas J Polascik
Department of Surgery, DUMC, Durham, NC, USA
Mack T Ruffin, IV
Department of Family Medicine and University of Michigan Community Clinical Oncology Program Research Base, University of Michigan, Ann Arbor, MI, USA
Robin T Vollmer
Department of Pathology, DUMC, Durham, NC, USA, Durham Veterans Administration Medical Center, Durham, NC, USA
Background: The time between the diagnosis of cancer and a planned definitive surgical procedure offers a strong and direct approach for assessing the impact of interventions (including lifestyle interventions) on the biology of the target tissue and the tumor. Despite the many strengths of presurgical models, there are practical issues and challenges that arise when using this approach.
Purpose:/Methods We recently completed an NIH-funded phase II trial that utilized a presurgical model in testing the comparative effects of flaxseed supplementation and/or dietary fat restriction on the biology and biomarkers associated with prostatic carcinoma. Herein, we report the rationale for our original design, discuss modifications in strategy, and relay experiences in implementing this trial related to the following topics: (1) subject accrual; (2) subject retention; (3) intervention delivery; and (4) retrieval and completion rates regarding the collection of paraffin-embedded and fresh frozen prostate tissue, blood, urine, ejaculate, anthropometric measures and survey data.
Results: This trial achieved its accrual target, i.e., a racially-representative (70% white, 30% minority) sample of 161 participants, low rates of attrition (7%); and collection rates that exceeded 90% for almost all biospecimens and survey data. While the experience gained from pilot studies was invaluable in designing this trial, the complexity introduced by the collection of several biospecimens, inclusion of a team of pathologists (to provide validated readings), and shifts in practice patterns related to prostatectomy, made it necessary to revise our protocol; lessons from our experiences are offered within this article.
Conclusions: While our experience specifically relates to the implementation of a presurgical model-based trial in prostate cancer aimed at testing flaxseed-supplemented and fat-restricted diets, many of the lessons learned have broad application to trials that utilize a presurgical model or dietary modification within various cancer populations. Clinical Trials 2008; 5: 262—272. http://ctj.sagepub.com
References
- Bostwick DG, Burke HB, Djakiew D., et al. Human prostate cancer risk factors . Cancer 2004; 101 (10 Suppl): 2371-490.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Kushi LH, Byers T., Doyle C., et al. American cancer society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity . CA Cancer J Clin 2006; 56: 254-81.[Abstract/Free Full Text]
- Lippman SM, Goodman PJ, Klein EA, et al. Designing the selenium and vitamin E cancer prevention trial (SELECT) . J Natl Cancer Inst 2005; 97: 94-102.[Abstract/Free Full Text]
- Lee JJ, Lieberman R., Sloan JA, et al. Design considerations for efficient prostate cancer chemoprevention trials . Urol 2001; 57 (4 Suppl 1): 205-12.
- Thompson IM, Tangen CM, Klein EA, et al. Phase III prostate cancer prevention trials: are the costs justified? J Clin Oncol 2005; 23: 8161-64.[Abstract/Free Full Text]
- Dowsett M. Preoperative models to evaluate endocrine strategies for breast cancer . Clin Cancer Res 2003; 9: 502S-10S.[Abstract/Free Full Text]
- Kim J., Sun P., Lam YW, et al. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer . Cancer Epidemiol Biomarkers Prev 2005; 14: 1697-702.[Abstract/Free Full Text]
- Adlercreutz H. Epidemiology of phytoestrogens . Baillieres Clin Endocrinol Metab 1998; 12: 605-23.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Freeman VL, Meydani M., Hur K., Flanigan RC Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma . Cancer 2004; 101: 2744-54.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Griffiths K., Denis L., Turkes A., Morton MS Phytoestrogens and diseases of the prostate gland . Baillieres Clin Endocrinol Metab 1998; 12: 625-47.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Morton MS, Turkes A., Denis L., Griffiths K. Can dietary factors influence prostatic disease? BJU Int 1999; 84: 549-54.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Ritch CR, Wan RL, Stephens LB, et al. Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men . J Urol 2007; 177: 97-101.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Webb AL, McCullough ML Dietary lignans: potential role in cancer prevention . Nutr Cancer 2005; 51: 117-31.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Lands WE, Libelt B., Morris A. Maintenance of lower proportions of (n - 6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n - 3) fatty acids . Biochim Biophys Acta 1992; 1180: 147-62.[Medline]
[Order article via Infotrieve]
- Lin X., Switzer BR, Demark-Wahnefried W. Effect of mammalian lignans on the growth of prostate cancer cell lines . Anticancer Res 2001; 21(6A): 3995-99.[ISI][Medline]
[Order article via Infotrieve]
- Lin X., Gingrich JR, Bao W., et al. Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice . Urol 2002; 60: 919-24.[CrossRef][Medline]
[Order article via Infotrieve]
- Demark-Wahnefried W., Robertson CN, Walther PJ Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen . Urol 2004; 63: 900-04.[CrossRef][Medline]
[Order article via Infotrieve]
- Bostwick DG, Aquilina JW Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials . J Cell Biochem Suppl 1996; 25: 156-64.[Medline]
[Order article via Infotrieve]
- Allam CK, Bostwick DG, Hayes JA Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma . Mod Pathol 1996; 9: 742-51.[ISI][Medline]
[Order article via Infotrieve]
- Wills ML, Hamper UM, Partin AW, Epstein JI Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens . Urol 1997; 49: 367-73.[CrossRef][Medline]
[Order article via Infotrieve]
- Demark-Wahnefried W., Price DT, Polascik TJ, et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features . Urol 2001; 58: 47-52.[CrossRef][Medline]
[Order article via Infotrieve]
- Simon R., Freedman LS Bayesian design and analysis of two x two factorial clinical trials . Biometr 1997; 53: 456-64.[CrossRef]
- Shultz TD, Howie BJ In vitro binding of steroid hormones by natural and purified fibers . Nutr Cancer 1986; 8: 141-47.[Medline]
[Order article via Infotrieve]
- Bostwick DG, Montironi R., Nogle R., et al. Current and proposed biologic markers in prostate cancer . J Cell Biochem Suppl 1992; 16H: 65-67.
- Kucuk O. Chemoprevention of prostate cancer . Cancer Metastasis Rev 2002; 21: 111-24.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Bloedon LT, Szapary PO Flaxseed and cardiovascular risk . Nutr Rev 2004; 62(1): 18-27.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Hager MH, Solomon KR, Freeman MR The role of cholesterol in prostate cancer . Curr Opin Clin Nutr Metab Care 2006; 9: 379-85.[ISI][Medline]
[Order article via Infotrieve]
- Kasim-Karakas SE, Tsodikov A., Singh U. Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake . Am J Clin Nutr 2006; 83: 774-79.[Abstract/Free Full Text]
- Sonn GA, Aronson W., Litwin MS Impact of diet on prostate cancer: a review . Prostate Cancer Prostat Dis 2005; 8: 304-10.[CrossRef]
- Hamalainen EK, Adlercreutz H., Puska P. Decrease of serum total and free testosterone during a low-fat high-fibre diet . J Steroid Biochem 1983; 18: 369-70.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Machin DCM. Statistical tables for the design of clinical trials, 2nd edn. Blackwell, Oxford, 1996.
- Polascik TJ, Oesterling JE, Partin AW Prostate specific antigen: a decade of discovery-what we have learned and where we are going . J Urol 1999; 162: 293-306.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Bligh EG, Dyer WJ A rapid method of total lipid extraction and purification . Can J Biochem Physiol 1959; 37: 911-17.[Medline]
[Order article via Infotrieve]
- Morton MS, Chan PS, Cheng C. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom . Prostate 1997; 32: 122-28.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Lampe JW, Martini MC, Kurzer MS Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder . Am J Clin Nutr 1994; 60: 122-28.[Abstract/Free Full Text]
- Freedland SJ, Grubb KA, Yiu SK, et al. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center . J Urol 2005; 174: 919-22.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Subar AF, Thompson FE, Kipnis V., et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study . Am J Epidemiol 2001; 154: 1089-99.[Abstract/Free Full Text]
- Thompson FE, Subar AF, Brown CC, et al. Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study . J Am Diet Assn 2002; 102: 212-25.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Kohl HW, Blair SN, Paffenbarger Jr RS A mail survey of physical activity habits as related to measured physical fitness . Am J Epidemiol 1988; 127: 1228-39.[Abstract/Free Full Text]
- Thompson LU Experimental studies on lignans and cancer . Baillieres Clin Endocrinol Metab 1998; 12: 691-705.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Stasse-Wolthuis M., Hautvast JG, Hermus RJ, et al. The effect of a natural high-fiber diet on serum lipids, fecal lipids, and colonic function . Am J Clin Nutr 1979; 32: 1881-88.[Abstract/Free Full Text]
- Farmer KC Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice . Clin Therapeut 1999; 21: 1074-90.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Rogatko A., Babb JS, Wang H. Patient characteristics compete with dose as predictors of acute treatment toxicity in early phase clinical trials . Clin Cancer Res. 2004; 10: 4645-51.[Abstract/Free Full Text]
- Tateyama H., Tada T., Hattori H., et al. Effects of prefixation and fixation times on apoptosis detection by in situ end-labeling of fragmented DNA . Arch Pathol Lab Med 1998; 122: 252-55.[ISI][Medline]
[Order article via Infotrieve]
- Tefilli MV, Gheiler EL, Tiguert R., et al. Should Gleason score 7 prostate cancer be considered a unique grade category? Urol 1999; 53: 372-77.[CrossRef][Medline]
[Order article via Infotrieve]
- Rojavin MA Recruitment index as a measure of patient recruitment activity in clinical trials . Contemp Clin Trials 2005; 26: 552-56.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Bolen S., Tilburt J., Baffi C., et al. Defining ``success'' in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach . Cancer 2006; 106: 1197-204.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- American Cancer Society. Cancer Facts and Figures, 2007. ACS, Atlanta, 2007.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
|